[1]Patent:US4639334,1987,A
[2]Patent:US4560507,1985,A
[1]Patent:WO2017/19819,2017,A1.Locationinpatent:Page/Pagecolumn123
903549-49-5 | 5-trans Latanoprost (free acid) | AA006RHT | MFCD08056093
915925-33-6 | N-[(5-Isobutyl-1,2,4-oxadiazol-3-yl)methyl]ethanamine | AA006SSQ | MFCD08691630
915920-26-2 | N-(2-Butyl-6-methylpyrimidin-4-yl)ethane-1,2-diamine | AA006TCJ | MFCD08691668
152434-88-3 | 2,6-Difluoro-3-hydroxybenzaldehyde | AA006TZK | MFCD08275284
503425-86-3 | 2-Amino-3,6-dibromopyridine | AA006UM6 | MFCD03230008
143361-89-1 | 3-(1H-Benzo[d]imidazol-2-yl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-amine | AA006V8Z | MFCD00649220
500891-66-7 | 1-(2,5-Dimethylthiophen-3-yl)butan-1-one | AA006VXK | MFCD08059889
139-89-9 | Sodium 2,2'-((2-((carboxylatomethyl)(2-hydroxyethyl)amino)ethyl)azanediyl)diacetate | AA006WEE | MFCD00043341
23466-27-5 | Ethyl 1-methyl-1h-pyrrole-2-carboxylate | AA006X1D | MFCD02179573
24045-73-6 | Ethyl 2-chloro-3-oxopentanoate | AA006XIW | MFCD20621220